-
2
-
-
0036885055
-
Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States
-
Pool V, Braun MM, Kelso JM, et al. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics 2002;110:e71.
-
(2002)
Pediatrics
, vol.110
-
-
Pool, V.1
Braun, M.M.2
Kelso, J.M.3
-
4
-
-
0038321369
-
Anaphylaxis and emergency treatment
-
Sampson HA. Anaphylaxis and emergency treatment. Pediatrics 2003;111:1601-8.
-
(2003)
Pediatrics
, vol.111
, pp. 1601-1608
-
-
Sampson, H.A.1
-
5
-
-
34447332895
-
Vaccine safety and the management of adverse events following immunisation
-
Department of Health, London: Department of Health
-
Department of Health. Vaccine safety and the management of adverse events following immunisation. Immunisation against infectious disease. London: Department of Health, 2006:53-64.
-
(2006)
Immunisation against infectious disease
, pp. 53-64
-
-
-
6
-
-
0038341614
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001
-
Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. MMWR Surveill Summ 2003;52:1-24.
-
(2003)
MMWR Surveill Summ
, vol.52
, pp. 1-24
-
-
Zhou, W.1
Pool, V.2
Iskander, J.K.3
-
7
-
-
0035256864
-
Allergic reactions to measles-mumps-rubella vaccination
-
Patja A, Makinen-Kiljunen S, Davidkin I, et al. Allergic reactions to measles-mumps-rubella vaccination. Pediatrics 2001;107:e27.
-
(2001)
Pediatrics
, vol.107
-
-
Patja, A.1
Makinen-Kiljunen, S.2
Davidkin, I.3
-
8
-
-
0141890074
-
Risk of anaphylaxis after vaccination of children and adolescents
-
Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003;112:815-20.
-
(2003)
Pediatrics
, vol.112
, pp. 815-820
-
-
Bohlke, K.1
Davis, R.L.2
Marcy, S.M.3
-
9
-
-
4344610304
-
Clinical features and severity grading of anaphylaxis
-
Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004;114:371-6.
-
(2004)
J Allergy Clin Immunol
, vol.114
, pp. 371-376
-
-
Brown, S.G.1
-
10
-
-
3242891909
-
Mast cell tryptase: A review of its physiology and clinical significance
-
Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 2004;59:695-703.
-
(2004)
Anaesthesia
, vol.59
, pp. 695-703
-
-
Payne, V.1
Kam, P.C.2
-
11
-
-
0034124376
-
Postmortem findings after fatal anaphylactic reactions
-
Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000;53:273-6.
-
(2000)
J Clin Pathol
, vol.53
, pp. 273-276
-
-
Pumphrey, R.S.1
Roberts, I.S.2
-
13
-
-
2342591290
-
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
-
Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-6.
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 832-836
-
-
Johansson, S.G.1
Bieber, T.2
Dahl, R.3
-
14
-
-
0842299685
-
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force
-
Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-24.
-
(2001)
Allergy
, vol.56
, pp. 813-824
-
-
Johansson, S.G.1
Hourihane, J.O.2
Bousquet, J.3
-
15
-
-
31944443634
-
-
Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391-7.
-
Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391-7.
-
-
-
-
16
-
-
33644827296
-
Paediatric emergency department anaphylaxis: Different patterns from adults
-
Braganza SC, Acworth JP, Mckinnon DR, et al. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006;91:159-63.
-
(2006)
Arch Dis Child
, vol.91
, pp. 159-163
-
-
Braganza, S.C.1
Acworth, J.P.2
Mckinnon, D.R.3
-
17
-
-
0032991206
-
-
CIOMS. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XIII): clinical pathology and general disorders. Pharmacoepidemiol Drug Saf 1999;8:217-24.
-
CIOMS. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XIII): clinical pathology and general disorders. Pharmacoepidemiol Drug Saf 1999;8:217-24.
-
-
-
-
18
-
-
0000041831
-
Causation and causal inference
-
Rothman KJ, Greenland S, eds, Philadelphia: Lippincott-Raven
-
Rothman KJ. Causation and causal inference. In: Rothman KJ, Greenland S, eds. Modern epidemiology. Philadelphia: Lippincott-Raven, 1998:7-28.
-
(1998)
Modern epidemiology
, pp. 7-28
-
-
Rothman, K.J.1
-
19
-
-
34447313673
-
-
Epub ahead of print
-
Ruggeberg JU, Gold MS, Bayas JM, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2007. Epub ahead of print.
-
(2007)
Vaccine, Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
-
-
Ruggeberg, J.U.1
Gold, M.S.2
Bayas, J.M.3
|